Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer-Reference-Cited by-同舟云学术

Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer

Published:2017-12-20 Issue:3 Volume:39 Page:371-377
ISSN:1059-7794
Container-title:Human Mutation
language:en
Short-container-title:Human Mutation

Author:

Sponziello Marialuisa¹^ORCID,Benvenuti Silvia²,Gentile Alessandra²,Pecce Valeria¹,Rosignolo Francesca¹,Virzì Anna Rita²³,Milan Melissa²⁴,Comoglio Paolo M.²,Londin Eric⁵,Fortina Paolo⁶⁷,Barnabei Agnese⁸,Appetecchia Marialuisa⁸,Marandino Ferdinando⁹,Russo Diego¹⁰,Filetti Sebastiano¹,Durante Cosimo¹^ORCID,Verrienti Antonella¹

Affiliation:

1. Department of Internal Medicine and Medical Specialties; Sapienza University of Rome; Rome Italy

2. Molecular Therapeutics and Exploratory Research; Candiolo Cancer Institute - FPO, IRCCS; Candiolo Italy

3. Department of Oncology; University of Turin; Candiolo Italy

4. Department of Medical Oncology; Catholic University of the Sacred Heart; Rome Italy

5. Computational Medicine Center; Sidney Kimmel Medical College; Thomas Jefferson University; Philadelphia Pennsylvania

6. Cancer Genomics Laboratory; Sidney Kimmel Cancer Center; Department of Cancer Biology; Sidney Kimmel Medical College; Thomas Jefferson University; Philadelphia Pennsylvania

7. Department of Molecular Medicine; Sapienza University of Rome; Rome Italy

8. Unit of Endocrinology; Regina Elena National Cancer Institute; Rome Italy

9. Department of Pathology; Regina Elena National Cancer Institute; Rome Italy

10. Department of Health Sciences; “Magna Graecia” University of Catanzaro; Catanzaro Italy

Funder

Umberto Di Mario Foundation (UDMF)

Banca d'Italia (S.F.)

Sapienza Università di Roma

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Reference31 articles.

1. Genomic characterization of recurrent high-grade astroblastoma;Bale;Cancer Genetics,2016

2. Ron kinase transphosphorylation sustains MET oncogene addiction;Benvenuti;Cancer Research,2011

3. In vivo and in vitro characterization of a novel germline RET mutation associated with low-penetrant nonaggressive familial medullary thyroid carcinoma;D'Aloiso;Journal of Clinical Endocrinology and Metabolism,2006

4. RET fusion as a novel driver of medullary thyroid carcinoma;Grubbs;Journal of Clinical Endocrinology and Metabolism,2015

5. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation;Jaggard;Journal of Laryngology and Otology,2009

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NF1gene inactivation acts as a tumor driver inRET/RAS-negative medullary thyroid carcinomas;European Journal of Endocrinology;2023-05

2. Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma;Endocrine Pathology;2023-03

3. Medullary Thyroid Carcinoma;The Bethesda System for Reporting Thyroid Cytopathology;2023

4. The Molecular Pathology of Thyroid Cancer;Practical Management of Thyroid Cancer;2023

5. Neoplasms of the Thyroid Gland;Atlas of Head and Neck Pathology;2023